| ID Source | ID |
|---|---|
| PubMed CID | 97396 |
| CHEMBL ID | 1221712 |
| CHEBI ID | 163724 |
| SCHEMBL ID | 259179 |
| MeSH ID | M0257869 |
| Synonym |
|---|
| CHEMBL1221712 |
| 7758-33-0 |
| gly-his-gly |
| 2-[[(2s)-2-[(2-aminoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]acetic acid |
| CHEBI:163724 |
| glycyl-l-histidylglycine |
| glycyl-histidyl-glycine |
| nsc 120776 |
| glycine, n-(n-glycyl-l-histidyl)- |
| n-(n-glycyl-l-histidyl)glycine |
| glycine,glycyl-l-histidyl- |
| SCHEMBL259179 |
| h-gly-his-gly-oh |
| glycyl-l-histidyl-glycine |
| mfcd00022369 |
| (s)-2-(2-(2-aminoacetamido)-3-(1h-imidazol-4-yl)propanamido)acetic acid |
| Class | Description |
|---|---|
| oligopeptide | A peptide containing a relatively small number of amino acids. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID500816 | Inhibition of nitrogen-starved wild type sigma1278b yeast Gap1-mediated amino acid uptake at 5 mM after 60 secs relative to L-citrulline | 2009 | Nature chemical biology, Jan, Volume: 5, Issue:1 | Transport and signaling via the amino acid binding site of the yeast Gap1 amino acid transceptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (16.67%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| pipecolic acid | [no description available] | medium | 1 | 0 | piperidinemonocarboxylic acid | |
| taurine | [no description available] | medium | 1 | 0 | amino sulfonic acid; zwitterion | antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite |
| serine | [no description available] | medium | 1 | 0 | L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
| aspartic acid | [no description available] | medium | 1 | 0 | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
| lysine | [no description available] | medium | 1 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| tyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
| phenylalanine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| histidine | [no description available] | medium | 1 | 0 | amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
| threonine | [no description available] | medium | 1 | 0 | amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| tryptophan | [no description available] | medium | 1 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| citrulline | [no description available] | medium | 1 | 0 | amino acid zwitterion; citrulline | Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite |
| glycyl-glycyl-glycine | [no description available] | medium | 1 | 0 | tripeptide zwitterion; tripeptide | |
| glycylglycine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | human metabolite |
| glutamic acid | [no description available] | medium | 1 | 0 | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
| leucyltyrosine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| leucyl-glycyl-glycine | [no description available] | medium | 1 | 0 | tripeptide | metabolite |
| leucylleucine | [no description available] | medium | 1 | 0 | dipeptide; L-aminoacyl-L-amino acid zwitterion | human metabolite; Mycoplasma genitalium metabolite |
| leucyl-alanine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| leucyl-leucyl-leucine | [no description available] | medium | 1 | 0 | tripeptide | metabolite |
| glycyltryptophan | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| glycylleucine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | metabolite |
| glycyl-l-phenylalanine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | human metabolite; metabolite |
| aspartyl-phenylalanine | [no description available] | medium | 1 | 0 | dipeptide | human blood serum metabolite; human xenobiotic metabolite |
| glycylsarcosine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | |
| leucylleucine | [no description available] | medium | 1 | 0 | peptide | |
| glycyl-leucyl-tyrosine | [no description available] | medium | 1 | 0 | oligopeptide | |
| glycyl-glycyl-proline | [no description available] | medium | 1 | 0 | tripeptide zwitterion; tripeptide | |
| glycylaspartic acid | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| n-glycylglutamic acid | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| histidylglycine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| valylvaline | [no description available] | medium | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
| alpha-methylphenylalanine | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | |
| prolinamide | [no description available] | medium | 1 | 0 | amino acid amide; L-proline derivative; pyrrolidinecarboxamide | |
| tyrosyl-glycyl-glycine | [no description available] | medium | 1 | 0 | tripeptide zwitterion; tripeptide | metabolite |
| proline | [no description available] | medium | 1 | 0 | amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid | algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
| arginylarginine 2-naphthylamide | [no description available] | medium | 1 | 0 | ||
| histidylphenylalanine | [no description available] | medium | 1 | 0 | dipeptide | |
| glycyl-glycyl-valine | [no description available] | medium | 1 | 0 | oligopeptide | |
| glycyl-glycyl-sarcosine | [no description available] | medium | 1 | 0 | ||
| cysteinylglycine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite |
| glutamyl-glutamic acid | [no description available] | medium | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
| n-acetyltryptophan | [no description available] | medium | 1 | 0 | L-tryptophan derivative; N-acetyl-L-amino acid | metabolite |
| n-glycylalanine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| glycylvaline | [no description available] | medium | 1 | 0 | dipeptide | human metabolite |
| epsilon-tert-butyloxycarbonyl-lysine | [no description available] | medium | 1 | 0 | ||
| glycylproline | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | metabolite |
| tryptophanol | [no description available] | medium | 1 | 0 | ||
| phenylalanylglycine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| glycyl-alanyl-phenylalanine | [no description available] | medium | 1 | 0 | oligopeptide | |
| methionylglycine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| histidylhistidine | [no description available] | medium | 1 | 0 | dipeptide | Mycoplasma genitalium metabolite |
| valylleucine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| alanylglycine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | metabolite |
| alpha-glutamyltryptophan | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| methionylglutamic acid | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| phenylalanyl-valine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| homocarnosine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide; homocarnosine; L-histidine derivative; N-acyl-L-alpha-amino acid anion; N-acyl-L-alpha-amino acid | human metabolite |
| clove | [no description available] | medium | 1 | 0 | ||
| deuterium | [no description available] | medium | 1 | 0 | dihydrogen | |
| prolylglycine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | |
| aminolevulinic acid | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid; amino acid zwitterion; delta-amino acid | antineoplastic agent; dermatologic drug; Escherichia coli metabolite; human metabolite; mouse metabolite; photosensitizing agent; plant metabolite; prodrug; Saccharomyces cerevisiae metabolite |
| buserelin | [no description available] | low | 0 | 0 | oligopeptide | |
| goralatide | [no description available] | low | 0 | 0 | oligopeptide; tetrapeptide | anti-inflammatory agent; pro-angiogenic agent |
| posatirelin | [no description available] | low | 0 | 0 | oligopeptide | |
| amogastrin | [no description available] | low | 0 | 0 | oligopeptide | |
| phenylalanyl-phenylalanyl-phenylalanine | [no description available] | low | 0 | 0 | oligopeptide | |
| methionyl-leucyl-phenylalanine | [no description available] | low | 0 | 0 | oligopeptide | |
| msh release-inhibiting hormone | [no description available] | low | 0 | 0 | oligopeptide | |
| alanyl-glycyl-glycine | [no description available] | low | 0 | 0 | oligopeptide | |
| prolyl-glycyl-glycine | [no description available] | low | 0 | 0 | oligopeptide | |
| arginyl-glycyl-aspartic acid | [no description available] | low | 0 | 0 | oligopeptide | |
| bradykinin, des-arg(9)- | [no description available] | low | 0 | 0 | oligopeptide | bradykinin receptor B2 agonist |
| s-ethyl glutathione | [no description available] | low | 0 | 0 | oligopeptide | |
| enkephalin, ser(2), leu(5), thr(6)- | [no description available] | low | 0 | 0 | oligopeptide | |
| ta 0910 | [no description available] | low | 0 | 0 | oligopeptide | analgesic; neuroprotective agent; nootropic agent |
| morphiceptin | [no description available] | low | 0 | 0 | oligopeptide | |
| arg-3-hyp-7-phe-bradykinin | [no description available] | low | 0 | 0 | oligopeptide | bradykinin receptor antagonist |
| splenopentin | [no description available] | low | 0 | 0 | oligopeptide | |
| pyroglutamyl-glutamyl-proline amide | [no description available] | low | 0 | 0 | oligopeptide | |
| cgp 42112a | [no description available] | low | 0 | 0 | benzyl ester; oligopeptide; pyridinecarboxamide | angiotensin receptor agonist; anti-inflammatory agent; antineoplastic agent; neuroprotective agent; vasodilator agent |
| glycyl-glycyl-cysteine | [no description available] | low | 0 | 0 | oligopeptide | |
| msh (11-13) | [no description available] | low | 0 | 0 | oligopeptide | |
| rigin | [no description available] | low | 0 | 0 | oligopeptide | |
| glycyl-leucyl-phenylalanine | [no description available] | low | 0 | 0 | oligopeptide | |
| hemorphin 4 | [no description available] | low | 0 | 0 | oligopeptide | |
| splenotritin | [no description available] | low | 0 | 0 | oligopeptide | |
| leucyl-aspartyl-valine | [no description available] | low | 0 | 0 | oligopeptide | |
| seryl-lysyl-leucine | [no description available] | low | 0 | 0 | oligopeptide | |
| diprotin b | [no description available] | low | 0 | 0 | oligopeptide | |
| kinetensin | [no description available] | low | 0 | 0 | oligopeptide | histamine releasing agent; human metabolite |
| lysyl-tyrosyl-lysine | [no description available] | low | 0 | 0 | oligopeptide | |
| phenylalanyl-phenylalanyl-glycine | [no description available] | low | 0 | 0 | oligopeptide | |
| prolyl-prolyl-glycine | [no description available] | low | 0 | 0 | oligopeptide | |
| ustiloxin d | [no description available] | low | 0 | 0 | oligopeptide | |
| lysyl-tryptophyl-alpha-lysine | [no description available] | low | 0 | 0 | oligopeptide | |
| pentigide | [no description available] | low | 0 | 0 | oligopeptide | |
| rhizonin a | [no description available] | low | 0 | 0 | oligopeptide | |
| bradykinin, des-phe(8)-des-arg(9)- | [no description available] | low | 0 | 0 | oligopeptide | human metabolite; rat metabolite |
| prolyl-leucyl-glycine | [no description available] | low | 0 | 0 | oligopeptide | |
| bradykinin, hydroxy-pro(3)- | [no description available] | low | 0 | 0 | oligopeptide; peptide hormone | bradykinin receptor agonist; human urinary metabolite |
| glycyl-prolyl-arginine | [no description available] | low | 0 | 0 | oligopeptide | |
| kentsin | [no description available] | low | 0 | 0 | oligopeptide | |
| cadystin protein, s pombe | [no description available] | low | 0 | 0 | oligopeptide; phytochelatin | |
| cilengitide | [no description available] | low | 0 | 0 | oligopeptide | |
| s-benzoylmercaptoacetyltriglycine | [no description available] | low | 0 | 0 | oligopeptide | |
| fertirelin | [no description available] | low | 0 | 0 | oligopeptide | |
| bradykinin | [no description available] | low | 0 | 0 | oligopeptide | human blood serum metabolite; vasodilator agent |
| elastin | [no description available] | low | 0 | 0 | oligopeptide | |
| phenylalanyl-prolyl-arginine | [no description available] | low | 0 | 0 | oligopeptide | |
| thymopentin | [no description available] | low | 0 | 0 | oligopeptide | |
| gonadotropin-releasing hormone | [no description available] | low | 0 | 0 | oligopeptide; peptide hormone | gonadotropin releasing hormone agonist |
| leuprolide | [no description available] | low | 0 | 0 | oligopeptide | anti-estrogen; antineoplastic agent; gonadotropin releasing hormone agonist |
| telaprevir | [no description available] | low | 0 | 0 | cyclopentapyrrole; cyclopropanes; oligopeptide; pyrazines | antiviral drug; hepatitis C protease inhibitor; peptidomimetic |
| rgh 0205 | [no description available] | low | 0 | 0 | oligopeptide | |
| leucyl-prolyl-proline | [no description available] | low | 0 | 0 | oligopeptide | |
| glycyl-prolyl-glutamic acid | [no description available] | low | 0 | 0 | oligopeptide | |
| spinorphin | [no description available] | low | 0 | 0 | oligopeptide | |
| trimethionine | [no description available] | low | 0 | 0 | oligopeptide | |
| cyclo(d-tyrosyl-arginyl-arginyl-3-(2-naphthyl)alanyl-glycyl) | [no description available] | low | 0 | 0 | oligopeptide | |
| atosiban | [no description available] | low | 0 | 0 | oligopeptide | |
| endomorphin 1 | [no description available] | low | 0 | 0 | oligopeptide | |
| l796778 | [no description available] | low | 0 | 0 | benzenes; C-nitro compound; L-lysine derivative; L-phenylalanine derivative; methyl ester; oligopeptide; secondary carboxamide; ureas | somatostatin receptor agonist |
| dermorphin | [no description available] | low | 0 | 0 | oligopeptide | |
| saralasin | [no description available] | low | 0 | 0 | oligopeptide | |
| phomopsin | [no description available] | low | 0 | 0 | oligopeptide | |
| montirelin | [no description available] | low | 0 | 0 | oligopeptide | |
| icatibant | [no description available] | low | 0 | 0 | oligopeptide | beta-adrenergic antagonist; bradykinin receptor antagonist; peptidomimetic |
| (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | [no description available] | low | 0 | 0 | oligopeptide | |
| diglycyl-histidine | [no description available] | low | 0 | 0 | oligopeptide | |
| davunetide | [no description available] | low | 0 | 0 | oligopeptide | |
| sincalide | [no description available] | low | 0 | 0 | oligopeptide | |
| p 829 | [no description available] | low | 0 | 0 | oligopeptide | |
| bremelanotide | [no description available] | low | 0 | 0 | oligopeptide | |
| isoleucyl-prolyl-proline | [no description available] | low | 0 | 0 | oligopeptide | |
| angiotensin amide | [no description available] | low | 0 | 0 | oligopeptide | |
| arginyl-glycyl-serine | [no description available] | low | 0 | 0 | oligopeptide | |
| phakellistatin 13 | [no description available] | low | 0 | 0 | oligopeptide | |
| isoleucyl-valyl-tyrosine | [no description available] | low | 0 | 0 | oligopeptide | |
| ulimorelin | [no description available] | low | 0 | 0 | oligopeptide | |
| glycyl-prolyl-hydroxyproline | [no description available] | low | 0 | 0 | oligopeptide | |
| bms-650032 | [no description available] | low | 0 | 0 | oligopeptide | |
| ceruletide | [no description available] | low | 0 | 0 | oligopeptide | diagnostic agent; gastrointestinal drug |
| teicoplanin aglycone | [no description available] | low | 0 | 0 | oligopeptide | |
| s-(2-chloroethyl)glutathione | [no description available] | low | 0 | 0 | oligopeptide | |
| cetrorelix | [no description available] | low | 0 | 0 | oligopeptide | antineoplastic agent; GnRH antagonist |
| nafarelin | [no description available] | low | 0 | 0 | oligopeptide | anti-estrogen; gonadotropin releasing hormone agonist |
| deslorelin | [no description available] | low | 0 | 0 | oligopeptide | |
| histrelin | [no description available] | low | 0 | 0 | oligopeptide | antineoplastic agent; gonadotropin releasing hormone agonist |
| apelin-13 peptide | [no description available] | low | 0 | 0 | oligopeptide | antihypertensive agent; autophagy inhibitor; biomarker; human metabolite; neuroprotective agent |
| arginyl-glycyl-glutamic acid | [no description available] | low | 0 | 0 | oligopeptide | |
| callipeltin a | [no description available] | low | 0 | 0 | cyclodepsipeptide; guanidines; lactone; oligopeptide; phenols | anti-HIV-1 agent; antifungal agent; metabolite |
| lysyl-glutamyl-aspartic acid | [no description available] | low | 0 | 0 | oligopeptide | |
| gamma-glutamylfelinylglycine | [no description available] | low | 0 | 0 | oligopeptide | |
| alanyl-glutamyl-aspartic acid | [no description available] | low | 0 | 0 | oligopeptide | |
| N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide | [no description available] | low | 0 | 0 | aldehyde; indolecarboxamide; oligopeptide; pyrrolidin-2-ones; secondary carboxamide | anticoronaviral agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor |
| apelin-12 peptide | [no description available] | low | 0 | 0 | oligopeptide | biomarker; human blood serum metabolite; human metabolite; neuroprotective agent |
| 3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide | [no description available] | low | 0 | 0 | aldehyde; indolecarboxamide; monofluorobenzenes; oligopeptide; pyrrolidin-2-ones; secondary carboxamide | anticoronaviral agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|